JPRN-UMIN000005000
Not yet recruiting
未知
Studies on the usefulness of the metabolic imaging against arterial chemoradiation therapy for head and neck cancer - Methionine PET study for head and neck cancer
Tokushima University Hospital Department of Radiology0 sites10 target enrollmentFebruary 3, 2011
Conditionshead and neck cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- head and neck cancer
- Sponsor
- Tokushima University Hospital Department of Radiology
- Enrollment
- 10
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who can not receive a conventional arterial infusion chemotherapy and radiotherapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Metabolic Imaging to Improve Patient-Specific Therapy OutcomeNL-OMON55904Academisch Medisch Centrum70
Active, not recruiting
Phase 1
Multiorgan Metabolic imaging response assessment of Abemaciclib: the MiMe-A trialEUCTR2017-000123-28-FRInstitut Jules Bordet185
Active, not recruiting
Phase 1
Multiorgan Metabolic imaging response assessment of Abemaciclib: the MiMe-A trialesophageal ADC, esophageal SCC, Cholangiocarcinoma, urothelial cancer (progressive after immunotherapy), or endometrial cancerMedDRA version: 20.0Level: LLTClassification code 10055458Term: Esophageal adenocarcinomaSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10055476Term: Esophageal squamous cell carcinomaSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10008595Term: Cholangiocarcinoma NOSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10014735Term: Endometrial cancer NOSSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2017-000123-28-BEInstitut Jules Bordet185
Active, not recruiting
Phase 1
Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With GlioblastomaGlioblastoma Multiforme (GBM)NCT04019002Susan Chang17
Completed
Not Applicable
How well the CTscan findings and findings on PET-CT can predict how a patient with NPC will behaveHealth Condition 1: null- Nasopharyngeal CancerCTRI/2018/02/011982A100